Max Healthcare Institute Ltd. (MAXHEALTH) 52 Week Low Streak: Second Straight Session

Max Healthcare Institute Ltd. 52 Week Low Streak is now in its second straight session, with the stock again trading within 2% of its 52-week low. The cumulative move across the streak stands at -7.53%, while the latest trading range kept the stock near its yearly low. The supplied data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.

At 01 October 2026 at 9:23 AM IST, Max Healthcare Institute Ltd. share price was at Rs 909.9 versus the previous close of Rs 929.7, after opening at Rs 925 and touching an intraday high of Rs 925 and a low of Rs 902. The company’s market capitalisation stood at Rs 95,768.86 crore. For readers, the repeated-low pattern matters more than a single-day move because it shows the stock has stayed under pressure across multiple sessions rather than only reacting once.

Max Healthcare Institute Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 909.9
Previous Close	Rs 929.7
Today's Move	Rs -19.8 (-2.13%)
Open	Rs 925
High	Rs 925
Low	Rs 902
Market Capitalisation	Rs 95,768.86 crore

Max Healthcare Institute Ltd. (MAXHEALTH) traded at Rs 909.9 versus the previous close of Rs 929.7, a fall of 2.13%. The stock opened at Rs 925, reached a high of Rs 925, touched a low of Rs 902.

Max Healthcare Institute Ltd. share price was under pressure in early trade, last traded at Rs 909.9, down Rs 19.8 or 2.13% from the previous close of Rs 929.7. The day opened at Rs 925 and moved between Rs 902 and Rs 925, keeping the stock in the lower half of its intraday range and close to the day’s low. That pattern fits the broader Max Healthcare Institute Ltd. 52 Week Low Streak backdrop rather than an isolated dip.

The repeated weakness is important because the stock has now stayed near its 52-week trough for another session after first testing that zone on 30 September 2026. In this kind of setup, readers usually focus less on the day’s percentage move and more on whether the decline is persisting across sessions. For Max Healthcare Institute Ltd. Stock News tracking, the current market capitalisation of Rs 95,768.86 crore also matters because it places the move in a large, widely tracked healthcare name. The Max Healthcare Institute Ltd. Share Price Today action therefore shows continued downside pressure, not a one-off intraday slip.

What the Repeated 52-Week Lows Show

The Max Healthcare Institute Ltd. 52 Week Low Streak points to a market that is still pricing the stock close to its one-year trough for more than one session. On the data supplied, this is not a fresh all-time low story or a record-low story; it is a repeated near-52-week-low pattern. The cumulative decline of -7.53% across the streak is the key signal, because it shows the weakness has persisted rather than fading after the first breakdown.

For investors screening Stocks Hitting 52 Week Lows or Stocks At One Year Low Today, the more useful question is whether the pattern is broad-based or stock-specific. Here, the supplied data confirms the Max Healthcare Institute Ltd. Consecutive 52 Week Low pattern, but it does not identify a fresh company event as the trigger. That distinction matters. A second straight session near the yearly low can reflect continued caution, but the data alone does not support a precise cause. The repeated-low setup also keeps Max Healthcare Institute Ltd. Back To Back 52 Week Lows in focus for market participants following healthcare sector trends.

Max Healthcare Institute Ltd. (MAXHEALTH) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 95,768.86 crore
P/E Ratio	62.11x
P/B Ratio	8.28x
ROE	14.53%
ROCE	14.97%
EPS	Rs 14.97
Book Value Per Share	Rs 112.27
Dividend Yield	0.22%

Max Healthcare Institute Ltd. (MAXHEALTH) fundamental metrics show P/E 62.11x, P/B 8.28x, ROE 14.53%, ROCE 14.97%. These figures provide context only and are not a buy or sell signal.

Max Healthcare Institute Ltd. has a market capitalisation of Rs 95768.86 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.11x, P/B at 8.28x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.53% and ROCE of 14.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 14.97, book value per share of Rs 112.27, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 39.03x, median ROE of 12.88%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	62.11x
Benchmark Median P/E	39.03x
Benchmark Average P/E	87.79x
Benchmark P/E Range	0x to 1,608.25x
Company P/B Ratio	8.28x
Benchmark Median P/B	3.75x
Company ROE	14.53%
Benchmark Median ROE	12.88%
Company ROCE	14.97%
Benchmark Median ROCE	15.84%
Company Market Capitalisation	Rs 95,768.86 crore
Benchmark Median Market Cap	Rs 558.66 crore

Max Healthcare Institute Ltd. (MAXHEALTH) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 62.11x, which is above the benchmark median of 39.03x, a difference of +59.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Max Healthcare Institute Ltd. (MAXHEALTH) has a ROE of 14.53%, which is above the benchmark median of 12.88%, a difference of +12.81%. Max Healthcare Institute Ltd. (MAXHEALTH) has a ROCE of 14.97%, which is below the benchmark median of 15.84%, a difference of -5.49%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	98,508.6	104.47	5.11	12.95	13.93
Apollo Hospitals Enterprise Ltd.	APOLLOHOSP	1,25,119.97	56	12.08	23.54	21.73
Aster DM Healthcare Ltd.	ASTERDM	64,094.07	190.26	14.33	13.07	16.22
Fortis Healthcare Ltd.	FORTIS	61,831.07	55.35	5.71	11.32	14.07
Global Health Ltd.	MEDANTA	38,059.23	65.97	8.92	15.12	19.38

Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 62.11x compared with the displayed peer median of 65.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.53% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 14.97% versus the displayed peer median of 16.22%, providing a capital-efficiency comparison. Max Healthcare Institute Ltd. (MAXHEALTH) has a market capitalisation of Rs 95,768.86 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching

• The Max Healthcare Institute Ltd. 52 Week Low Streak has lasted for a second straight session, keeping the stock near its one-year trough.
• The cumulative move across the streak is -7.53%, which makes the repeated weakness more relevant than a single-day decline.
• The stock’s P/E of 62.11 and P/B of 8.28 remain above the healthcare industry medians.
• The market capitalisation of Rs 95,768.86 crore keeps Max Healthcare Institute Ltd. in focus among large healthcare names.
• Investors tracking Max Healthcare Institute Ltd. Stock News will want to see whether the repeated low pattern continues or stabilises from here.

About the Company

Max Healthcare Institute Ltd. is part of the Hospital & Healthcare Services industry under the Healthcare sector. The company is followed closely by investors because it combines a large market capitalisation with a valuation profile that tends to be compared against other premium healthcare names. In a market where Max Healthcare Institute Ltd. Share Price is often measured against industry return ratios, the current setup makes the stock a notable entry in the Max Healthcare Institute Ltd. 52 Week Low Streak category.

The business profile matters because healthcare investors usually watch operating margins, return ratios and valuation together rather than in isolation. The supplied data shows a company with ROE of 14.53%, ROCE of 14.97%, EPS of 14.97 and book value of Rs 112.27. That combination gives context to the recent weakness without turning it into a company-specific explanation. For readers scanning Max Healthcare Institute Ltd. Stock Analysis and Max Healthcare Institute Ltd. Company News, the main takeaway is that the stock remains near its yearly low even while core financial metrics stay visible in the market’s valuation debate.

Frequently Asked Questions

What does the Max Healthcare Institute Ltd. 52 Week Low Streak mean?

Ans. It means Max Healthcare Institute Ltd. has traded within 2% of its 52-week low for a second straight session. The pattern shows repeated weakness near the yearly low, but the data does not confirm a specific company event behind it.

How much has Max Healthcare Institute Ltd. moved across the streak?

Ans. The cumulative move across the Max Healthcare Institute Ltd. 52 Week Low Streak is -7.53%. That figure is more useful than the day’s change alone because it captures the full repeated-low pattern across consecutive sessions.

Did Max Healthcare Institute Ltd. make a new all-time low?

Ans. No such claim can be made from the supplied data. The event here is a near 52-week low streak, not an all-time low event, and the numbers only support a one-year-low context.

Why is Max Healthcare Institute Ltd. still in the Stocks Hitting 52 Week Lows discussion?

Ans. Because the stock has remained within 2% of its 52-week low for multiple sessions. That keeps Max Healthcare Institute Ltd. in the Stocks Hitting 52 Week Lows conversation even without a fresh record low.

How does the valuation compare with the healthcare sector?

Ans. Max Healthcare Institute Ltd. trades at a P/E of 62.11 and P/B of 8.28, both above the healthcare industry medians supplied. That means the stock remains relatively expensive versus the industry, even after the recent decline.

What do the profitability ratios show?

Ans. The company has ROE of 14.53% and ROCE of 14.97%. ROE is slightly above the industry median, while ROCE is slightly below, so the profitability picture is mixed rather than uniformly strong.

What should investors monitor next in Max Healthcare Institute Ltd. Stock News?

Ans. Investors should watch whether the stock stays near its 52-week low for more sessions, how the valuation compares with peers, and whether the repeated-low pattern continues. The supplied data does not establish a cause, so the price pattern remains the.

Is Max Healthcare Institute Ltd. a focus stock in the healthcare peer set?

Ans. Yes, because it combines a large market capitalisation, a premium valuation and a repeated near-52-week-low pattern. That mix keeps Max Healthcare Institute Ltd. Share Price relevant for readers tracking healthcare sector performance and peer comparison.

Track Max Healthcare Institute Ltd. (MAXHEALTH) Share Price on Univest

Use Max Healthcare Institute Ltd. (MAXHEALTH) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.